Coherus Oncology, Inc. (CHRS)
NASDAQ·Healthcare·Biotechnology
$1.08
+0.47%
Mkt Cap $165.32M
Analyst Ratings
Buy
1
Hold
0
Sell
0
Price Target (4 analysts)
$6.02
Range $1.05 – $11.00
Implied Upside
+457.4%
Consensus $6.02 vs current $1.08
NASDAQ·Healthcare·Biotechnology
$1.08
+0.47%
Mkt Cap $165.32M
Buy
1
Hold
0
Sell
0
Price Target (4 analysts)
$6.02
Range $1.05 – $11.00
+457.4%
Consensus $6.02 vs current $1.08